Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Official Journal of the European Union L 211 of 12 June 2004)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/corrigendum/oj/L/2004/337/14@2004-11-13/en
Contents
A. 1. 1.2. 1.2.4.
In the Annex, on page 5, point A is replaced as follows: The following substance(s) is(are) inserted in Annex I (List of pharmacologically active substances for which maximum residue limits have been fixed). Anti-infectious agents Antibiotics Macrolides Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopy-ranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Bovine 100 μg/kg Fat 3000 μg/kg Liver 3000 μg/kg Kidney Porcine 100 μg/kg Skin + fat 3000 μg/kg Liver 3000 μg/kg Kidney